Updated:
Hector Ventures
Hector Ventures was formed in 2021 by Paul Yde. His background includes more than 35 years representing clients before the DOJ and FTC on antitrust matters in...
Hector Ventures
Hector Ventures was formed in 2021 by Paul Yde. His background includes more than 35 years representing clients before the DOJ and FTC on antitrust matters in M&A and intellectual property. The firm serves as the single-family office for the Yde family. The office concentrates on venture capital in healthcare services and digital health. It makes direct co-investments and fund commitments in early-stage companies. Focus areas include biotech platforms addressing neurodevelopmental disorders and traumatic brain injury. Activity remains limited to North America. Paul Yde and Mark Yde serve as managing partners. Mark Yde contributes experience in biotechnology segments including cell and gene therapy. No additional offices or adjacent vehicles appear in public records. No operational events from the last 24 months are documented. The structure ties investment decisions directly to the founding principals without external fund vehicles or succession layers disclosed.
General information
Firm type
Single Family Office
Year founded
2021
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Washington
Corporate office
Washington, DC, United States
Principals
Paul Yde
Managing Partner
Mark Yde
Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Hector Ventures?
Paul Yde and Mark Yde serve as managing partners. Paul Yde handles commercial assessments drawing on his antitrust background. Mark Yde covers technical assessments in biotechnology.
Where does the underlying wealth come from?
Wealth originates from Paul Yde’s three-decade antitrust legal practice. No other sources are publicly disclosed.
What investment stages does Hector Ventures typically target?
The firm targets early-stage venture capital, including seed and start-up rounds. Commitments occur through direct co-investments and fund vehicles.
Which sectors does Hector Ventures focus on?
Allocations center on healthcare services, digital health, and biotech. Emphasis lies on neuroscience, med-tech, and therapeutic platforms for neurodevelopmental disorders and traumatic brain injury.
Does Hector Ventures participate in fund commitments or only direct deals?
The firm uses both direct co-investments and fund commitments. It also considers advisory roles and limited partnerships.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: